Characterization in vitro and in vivo of the pig analogue of human CD59 using new monoclonal antibodies

Immunology

Volumn 95, Issue 3, 1998, Pages 450-459

  Hanna, S M ^a   Williams, G T ^a   Van Den Berg, C W ^a   Morgan, B P ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CD59 ANTIGEN; MONOCLONAL ANTIBODY;

ANIMAL CELL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ANTIGEN PURIFICATION; ARTICLE; CONTROLLED STUDY; DEGLYCOSYLATION; ERYTHROCYTE MEMBRANE; IMMUNOHISTOCHEMISTRY; LEUKOCYTE; NONHUMAN; PRIORITY JOURNAL; THROMBOCYTE; TISSUE DISTRIBUTION;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, CD59; ANTIGENS, DIFFERENTIATION; BINDING, COMPETITIVE; CHROMATOGRAPHY, AFFINITY; ELECTROPHORESIS, POLYACRYLAMIDE GEL; FLOW CYTOMETRY; HUMANS; IMMUNOENZYME TECHNIQUES; SPECIES SPECIFICITY; SWINE; TISSUE DISTRIBUTION;

EID: 0031790048     PISSN: 00192805     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2567.1998.00623.x     Document Type: Article

References (23)

1. DAVIES A., SIMMONS D.L., HALE G. et al. (1989) CD59, an Ly-6-like protein expressed in human lymphoid cells, regulates the action of the complement membrane attack complex on homologous cells. J Exp Med 170, 637.
2. MERI S., WALDMANN H. & LACHMANN P.J. (1991) Distribution of protectin (CD59). a complement membrane attack inhibitor, in normal human tissues. Lab Invest 65, 532.
3. MERI S., MORGAN B.P., DAVIES A. et al. (1990) Human protectin (CD59), and 18 000 MW complement lysis restricting factor, inhibits C5b-8 catalysed insertion of C9 into lipid bilayers. Immunology 70, 1.
4. NINOMIYA H. & SIMS P.J. (1992) The human complement regulatory protein CD59 binds to the alpha chain of C8 and the 'b' domain of C9. J Biol Chem 267, 13675.
5. RUDD P.M., MORGAN B.P., WORMALD M.R. et al. (1997) The glycosylation of the complement regulatory protein, human erythrocyte CD59. J Biol Chem 272, 7229.
6. RUSHMERE N.K., TOMLINSON S. & MORGAN B.P. (1997) Expression of rat CD59: functional analysis confirms lack of species selectivity and reveals that glycosylation is not required for function. Immunology 90, 640.
7. HUGHES T.R., PIDDLESDEN S.J., WILLIAMS J.D., HARRISON R.A. & MORGAN B.P. (1992) Isolation and characterization of a membrane protein from rat erythrocytes which inhibits lysis by the membrane attack complex of rat complement. Biochem J 284, 169.
8. POWELL M.B., MARCHBANK K.J., RUSHMERE N.K., VAN DEN BERG, C.W. & MORGAN B.P. (1997) Molecular cloning, chromosomal localization, expression, and functional characterization of the mouse analogue of human CD59. J Immunol 158, 1692.
9. VAN DEN BERG C.W., HARRISON R.A. & MORGAN B.P. (1993) The sheep analogue of human CD59: purification and characterization of its complement inhibitory activity. Immunology 78, 349.
10. VAN DEN BERG C.W., HARRISON R.A. & MORGAN B.P. (1995) A rapid method for the isolation of analogues of human CD59 by preparative SDS PAGE: application to pig CD59. J Immunol Methods 179, 223.
11. HINCHLIFFE S.J., RUSHMERE N.K., HANNA S.M. & MORGAN B.P. (1998) Molecular cloning and functional characterization of the pig analogue of CD59; relevance to xenotranplantation. J Immunol 160, 3924.
12. FODOR W.L., ROLLINS S.A., BIANCOCARON S. et al. (1995) Primate terminal complement inhibitor homologs of human CD59. Immunogenetics 41, 51.
13. FUNIBASHI K., OKADA N., MATSUO S., YAMAMOTO T., MORGAN B.P. & OKADA H. (1994) Tissue distribution of complement regulatory membrane proteins in rats. Immunology 81, 444.
14. CARRINGTON C.A., RICHARDS A.C., VAN DEN BOGAERDE J., TUCKER A.W. & WHITE D.J.G. (1997) Complement activation, its consequences, and blockade by gene transfer. World J Surg 21, 907.
15. VAN DEN BERG C.W. & MORGAN B.P. (1994) Complement-inhibiting activities of human CD59 and analogues from rat, sheep and pig are not homologously restricted. J Immunol 152, 4095.
16. GALFRE G. & MILLSTEIN C. (1981) Preparation of monoclonal antibodies: strategies and procedures. Methods Enzymol 73, 3.
17. MORRISEY J.H. (1981) Silver stain for proteins in polyacrylamide gels: a modified procedure with enhanced uniform sensitivity. Anal Biochem 117, 307.
18. ABRAHA A., MORGAN B.P. & LUZIO J.P. (1988) The preparation and characterisation of monoclonal antibodies to human complement component C8 and their use in purification of C8 and C8 subunits. Biochem J 251, 285.
19. DIAMOND L.E., MCCURRY K.R., MARTIN M.J. et al. (1996) Characterization of transgenie pigs expressing functionally active human CD59 on cardiac endothelium. Transplantation 61, 1241.
20. DENECKE R., MANNUSS B. & TRAUTWEIN G. (1985) Immunological and enzyme histochemical identification of lymphocyte subpopulations in pig lymphoreticular tissues. Zbl Vet Med Bull 32, 660.
21. + CD3 lymphocytes (NK cells). Cell Immunol 165, 294.
22. TERSTAPPEN L.W.M.M., NGUYEN M., LAZARUS H.M. & MEDOF M.E. (1992) Expression of the DAF (CD55) and CD59 antigens during normal hematopoetic cell differentiation. J Leukocyte Biol 52, 652.
23. MORGAN B.P. (1992) Isolation and characterization of the complement-inhibiting protein CD59 antigen from platelet membranes. Biochem J 282, 409.